Mathematical model predicts resistance to Herceptin

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 18 No 8
Volume 18
Issue 8

Researchers at the University of Edinburgh in Scotland have built a mathematical model to determine the role of PTEN protein expression on resistance to trastuzumab (Herceptin).

Researchers at the University of Edinburgh in Scotland have built a mathematical model to determine the role of PTEN protein expression on resistance to trastuzumab (Herceptin).

Dana Faratian, MD, and colleagues used 56 differential equations to analyze the change in concentrations of 56 separate biological entities including proteins and lipid second messengers.

They worked with 122 breast cancers treated with trastuzumab and found that quantitative PTEN protein expression was a key determinant of who would be resistant or sensitive to trastuzumab. In addition, using the mathematical modeling techniques, the absence of PTEN was more predictive than could be determined using standard multivariate or laboratory analysis (Cancer Res online, July 21, 2009).

The results help explain why some patients still fail on tratuzumab, commented Sofia Merajver, MD, PhD, a Cancer Research editoral board member.

Recent Videos
Despite CD19 CAR T-cell therapy exhibiting efficacy in patients with relapsed/refractory large B-cell lymphoma, less than half achieve long-term remission.
4 experts in this video
4 experts in this video
“Dendritic cell vaccines, CAR T-cell therapy, and things of that nature are holding some promise,” said Andrew Brenner, MD, PhD.
Related Content